摘要
目的:通过整理近年来我国短缺药品目录,分析我国药品短缺现状与短缺原因,提出建议。方法:检索各省市药品短缺目录,结合市场竞争与产品生命周期理论,分析短缺药品供应保障现状。结果:目前我国短缺药品主要集中在心血管系统用药、抗肿瘤用药和神经系统用药,部分药品实际生产厂家数量与批文数量不符,短缺主要出现在产品的成熟期和衰退期。结论:应明确界定短缺药品,对不同类别的短缺情况分类区别处理,同时可以尝试新的短缺药品采购模式。
Objective To analyze the current situation and causes of drug shortage in China,and put forward some suggestions by sorting out the catalogue of drug shortage in recent years.Methods The catalogue of drug shortage in various provinces and cities was searched,and the current situation of drug shortage supply was analyzed based on the theory of market competition and product life cycle.Results At present,the drug shortage in China is mainly concentrated in cardiovascular system drug,antineoplastic drug and nervous system drug.The actual number of manufacturers of some drug does not match the number of approved documents,and the shortage mainly occurs in the maturity and decline period of products.Conclusion Drug shortage should be clearly defined,different types of shortage should be classified and dealt with distinction,and a new purchasing mode of drug short can be tried at the same time.
作者
朱雅萌
傅鸿鹏
ZHU Ya-meng;FU Hong-peng(School of Public Health,Capital Medical University,Beijing 100069,China;不详)
关键词
短缺药品
市场竞争
生命周期
drug shortage
market competition
life cycle